Press release
Ursodeoxycholic Acid Market: Segmentation Trends, Regional Opportunities, and Industry Growth Forecast to 2024-2031 | Glenmark Pharmaceuticals Inc., Biobrick Pharma, Casca Remedies Pvt. Ltd.
Ursodeoxycholic Acid Market || 2024-2031
Get a Free Sample PDF - https://datamintelligence.com/download-sample/ursodeoxycholic-acid-market
What is the projected growth rate (CAGR) of the Global Ursodeoxycholic Acid market from 2024 to 2031, and what is the market value expected to change by 2031?
The Global Ursodeoxycholic Acid Market reached US$ 581.17 million in 2023 and is expected to reach US$ 1120.55 million by 2031 growing with a CAGR of 9.8% during the forecast period 2024-2031.
What is Ursodeoxycholic Acid Market?
The ursodeoxycholic acid (UDCA) market focuses on the production and distribution of this bile acid, primarily used in the treatment of liver diseases, particularly primary biliary cholangitis (PBC) and gallstone dissolution. This market is experiencing growth due to the rising prevalence of liver disorders and the increasing awareness of the therapeutic benefits of UDCA.
Who are the major players in the Ursodeoxycholic Acid market?
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world. The prominent players in Ursodeoxycholic Acid market research report are: Glenmark Pharmaceuticals Inc., Biobrick Pharma, Casca Remedies Pvt. Ltd., Wellona Pharma, ADDII BIOTECH PRIVATE LIMITED., Curivo Healthcare, Zoic Life Sciences, Biofield Pharma Pvt Ltd, Jabs Biotech Pvt. Ltd, and Captee among others.
Key Development
In August 2024, Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi (seladelpar) to treat primary biliary cholangitis (PBC). This approval permits the use of Livdelzi in combination with ursodeoxycholic acid (UDCA) for adults who have not adequately responded to UDCA, as well as allowing it to be administered as a monotherapy for patients who cannot tolerate UDCA. This marks a significant advancement in treatment options for individuals with PBC, offering hope for improved patient outcomes.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=ursodeoxycholic-acid-market
Regions Covered:
The global Ursodeoxycholic Acid Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Market Segments
By Type: Synthetic Ursodeoxycholic Acid (UDCA), Biological Ursodeoxycholic Acid (UDCA).
By Application: Gallstones, Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Non-Alcoholic Fatty Liver Disease (NAFLD), Other Liver and Biliary Diseases.
By Form: Tablets, Capsules, Suspension.
The Ursodeoxycholic Acid industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Key Features
➥ Leverage epidemiology insights to tailor precision diagnostics and address region-specific needs.
➥ Meet critical unmet needs in complex conditions with advanced, precise Ursodeoxycholic Acid industry solutions for better diagnostics and outcomes.
➥ Stay ahead with real-time pipeline analysis, revealing the latest Ursodeoxycholic Acid innovations and market trends.
➥ Optimize your offerings with competitive pricing analysis, balancing cost-effectiveness and cutting-edge tech.
➥ Protect your innovation with expert patent analysis, ensuring strategic positioning in the Ursodeoxycholic Acid market.
➥ Gain an edge with comprehensive competitive intelligence, guiding informed decisions in Ursodeoxycholic Acid
➥ Maximize market presence with brand share analysis, strengthening your position in the Ursodeoxycholic Acid landscape.
➥ Accurately predict market demand for Ursodeoxycholic Acid with precise drug sales forecasting insights.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/ursodeoxycholic-acid-market
FAQs
What does the Ursodeoxycholic Acid market report provide?
The report provides a detailed analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Active, Innovators, Start-ups, and Cutting Edge) that are anticipated to influence its future growth trajectory.
What is the scope of the market report?
The market report covers regional analysis and provides detailed insights into the Ursodeoxycholic Acid market including market size, segmentation, and key players.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ursodeoxycholic Acid Market: Segmentation Trends, Regional Opportunities, and Industry Growth Forecast to 2024-2031 | Glenmark Pharmaceuticals Inc., Biobrick Pharma, Casca Remedies Pvt. Ltd. here
News-ID: 3712501 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Biofuels Market Set to Soar: Innovations and Sustainability Drive …
Market Size and Growth:
The Global Bio Fuels Market size was US$ 153.88 billion in 2024 and is expected to reach US$ 252.19 billion in 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).
The Biofuels Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
United States Food Encapsulation Market Poised for Expansion Amidst Clean Label …
Market Overview:
The Food Encapsulation Market is expected to grow at a CAGR of 8% during the forecast period 2024-2031.
The Food Encapsulation Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it…
United States Precious Metal Market Poised for Strong Growth Amid Rising Investm …
Market Size and Growth:
The Global Precious Metal Market size reached US$ 209.4 billion in 2023 and is expected to reach US$ 300.3 million by 2031, growing with a CAGR of 5.2% during the forecast period 2024-2031.
The Precious Metal Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
United States Anti-Obesity Drugs Market Set for Robust Growth with Rising Global …
Market Size and Growth:
The Global Anti-Obesity Drugs Market size reached US$ 2.5 billion in 2022 and is expected to reach US$ 43.7 billion by 2030 growing with a CAGR of 45.5% during the forecast period 2024-2031.
The Anti-Obesity Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
More Releases for Ursodeoxycholic
Oral Ursodeoxycholic Acid Market New Product Development & Latest Trends
The global oral ursodeoxycholic acid market is valued at approximately $850 million in 2024. Forecasts indicate a robust growth trajectory, anticipating a market value of around $1.5 billion by 2034. This growth reflects a Compound Annual Growth Rate (CAGR) of 6.4% from 2025 to 2034.
Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Oral Ursodeoxycholic Acid market…
Ursodeoxycholic Acid Market to see Booming Business Sentiments
The latest study released on the Global Ursodeoxycholic Acid Market by USD Analytics Research evaluates market size, trend, and forecast to 2030. The Ursodeoxycholic Acid market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players…
Ursodeoxycholic Acid API Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Ursodeoxycholic Acid API analysis, which studies the Electrical Cord Reels's industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global “Ursodeoxycholic Acid API 2020-2025” Research Report categorizes the global Ursodeoxycholic Acid API by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share,…
Ursodeoxycholic Acid Market Trends and Dynamic 2025 | Arcelor Chemicals
Global Ursodeoxycholic Acid Market: Overview
Ursodeoxycholic acid (UDCA) is essentially bile acid ingested in the liquid form or in the form of a tablet to cure gallstones. Those can cure or thwart the progress of cystic fibrosis-related liver disorder. UDCA transforms the bile acid pool by lowering the levels of hydrophobic bile acids. This increases the amount of nontoxic hydrophilic bile acids. Besides, UDCA can slow down the development of gastroesophageal…
Global Ursodeoxycholic Acid Industry Market Analysis & Forecast 2018-2023
Global Ursodeoxycholic Acid Industry has been utilized in the administration of puppies with incessant hepatitis and felines with lymphocytic plasmacytic cholangitis. It is accepted to be most useful in scatters where bile poisonous quality assumes an imperative job in the continuous pathology. The adequacy of Global Ursodeoxycholic Acid Industry in veterinary patients has not been certainly settled, in spite of the fact that reports recommend it might have some advantage…
Ursodeoxycholic Acid Market- ICE, Grindeks, Mitsubishi, Daewoong chemical, Pharm …
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3a, 7ß-2-hydroxy-5ß-bile acid, UDCA) was first found in the bile of a black bear.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. And the CAS number…
